Mouse models for abdominal aortic aneurysm

Jonathan Golledge,Smriti Murali Krishna,Yutang Wang
DOI: https://doi.org/10.1111/bph.15260
IF: 7.3
2020-10-21
British Journal of Pharmacology
Abstract:<p>Abdominal aortic aneurysm (AAA) rupture is estimated to cause 200,000 deaths each year. Currently the only treatment for AAA is surgical repair, however this is only indicated for large asymptomatic aneurysms, is not always durable and is associated with a risk of serious perioperative complications. As a result, patients with small aneurysms or who are otherwise unfit for surgery are treated conservatively, but up to 70% of small aneurysms continue to grow, increasing the risk of rupture. There is thus an urgent need to develop drug therapies effective at slowing AAA growth. This review describes the commonly used mouse models for AAA. Recent research in these models highlights key roles for pathways involved in inflammation and cell turnover in AAA pathogenesis. There is also evidence for long coding RNAs and thrombosis in aneurysm pathology. Further well‐designed research in clinically relevant models is expected to be translated into effective AAA drugs.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?